Management of Persistent Hypotony after Supraciliary CyPass(®) Implantation Using Argon Laser

PURPOSE: To report a case and management of persistent hypotony with hypotony-induced maculopathy after CyPass(®) device implant. BACKGROUND: The CyPass(®) was the first supraciliary ab interno device approved by FDA and commercially available. Efficacy studies showed adequate intraocular pressure (...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Del Valle-Nava, Díez-Cattini, GF, Alfonso, García-López, Francisco, Ortega-Santana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221243/
https://www.ncbi.nlm.nih.gov/pubmed/32431479
http://dx.doi.org/10.5005/jp-journals-10078-1259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221243/
https://www.ncbi.nlm.nih.gov/pubmed/32431479
http://dx.doi.org/10.5005/jp-journals-10078-1259

Ejemplares similares